You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pancreatic Adenocarcinoma Metastatic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in

Not yet recruiting
  • Pancreatic Adenocarcinoma Metastatic
    • Pessac, France
      CHU Bordeaux
    Aug 17, 2023

    Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • Nanjing, Jiangsu, China
      The Affiliated Nanjing Drum Tower Hospital of Nanjing University
    Sep 18, 2023

    Pancreatic Cancer Metastatic, Pancreatic Adenocarcinoma Metastatic Trial in Scottsdale (Botensilimab, Balstilimab, Chloroquine

    Not yet recruiting
    • Pancreatic Cancer Metastatic
    • Pancreatic Adenocarcinoma Metastatic
    • Scottsdale, Arizona
      Clinical Trials Nurse Navigator
    Oct 3, 2023

    Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +2 more
    • Enfortumab vedotin
    • Kansas City, Kansas
      University of Kansas Cancer Center
    Jun 23, 2023

    Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic Trial in Boston (FOLFIRNINOX, Losartan, 9-ING-41)

    Recruiting
    • Pancreatic Adenocarcinoma
    • Pancreatic Adenocarcinoma Metastatic
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Jun 7, 2022

    Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

    Recruiting
    • Pancreatic Adenocarcinoma Metastatic
    • +14 more
    • Boston, Massachusetts
    • +1 more
    Dec 6, 2022

    Metastatic Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in New

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • +12 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 30, 2022

    Cancer Of Pancreas Trial (Analyze of GemCore status)

    Not yet recruiting
    • Cancer Of Pancreas
    • Analyze of GemCore status
    • (no location specified)
    Sep 19, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma Trial in Washington (BXCL701, Pembrolizumab)

    Not yet recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Washington, District of Columbia
      Georgetown Lombardi Comprehensive Cancer Center
    Jan 23, 2023

    Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

    Not yet recruiting
    • Pancreatic Acinar Cell Carcinoma
    • +6 more
    • Nab paclitaxel
    • +5 more
    • (no location specified)
    Oct 30, 2023

    Metastatic Pancreatic Adenocarcinoma Trial (Avelumab and Pepinemab)

    Recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • Avelumab and Pepinemab
    • Rochester, New York
      University of Rochester Medical Center
    Jan 19, 2023

    Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Washington, District of Columbia
      Lombardi Comprehensive Cancer Center, Georgetown University
    Apr 11, 2023

    Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Durvalumab
    • Rintatolimod
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus MC
    Jun 23, 2023

    PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

    Not yet recruiting
    • PDAC - Pancreatic Ductal Adenocarcinoma
    • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
    • (no location specified)
    Jul 9, 2023

    Metastatic Pancreatic Ductal Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Seattle (Autologous Mesothelin-specific

    Recruiting
    • Metastatic Pancreatic Ductal Adenocarcinoma
    • Stage IV Pancreatic Cancer AJCC v8
    • Autologous Mesothelin-specific TCR-T Cells
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 31, 2023

    Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)

    Not yet recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • Ann Arbor, Michigan
      Rogel Cancer Center
    Jun 26, 2023

    Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Washington, District of Columbia
      Lombardi Comprehensive Cancer Center, Georgetown University
    Aug 24, 2023

    The HELPP Score: A Pretreatment Score to Predict Survival in

    Not yet recruiting
    • Pancreatic Adenocarcinoma
      • Vienna, Austria
        Department of General Surgery, Division of Visceral Surgery, Med
      Feb 21, 2023

      Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenocarcinoma Recurrent Trial in Italy (Decitabine 50 MG [Dacogen])

      Recruiting
      • Pancreatic Adenocarcinoma Metastatic
      • Pancreatic Adenocarcinoma Recurrent
      • Decitabine 50 MG [Dacogen]
      • Milano, Italy
      • +5 more
      Jul 13, 2022

      Pancreatic Ductal Adenocarcinoma Trial (OT-101, FOLFIRINOX)

      Not yet recruiting
      • Pancreatic Ductal Adenocarcinoma
      • (no location specified)
      Oct 5, 2023

      Pancreatic Cancer, Metastatic Adenocarcinoma Trial in Winston-Salem (Nab paclitaxel, Gemcitabine, TheraBionic)

      Not yet recruiting
      • Pancreatic Cancer
      • Metastatic Adenocarcinoma
      • Nab paclitaxel
      • +2 more
      • Winston-Salem, North Carolina
        Wake Forest Baptist Comprehensive Cancer Center
      Mar 8, 2023

      Metastatic Pancreatic Adenocarcinoma Trial in Shanghai (Ascorbate, Nab paclitaxel, Gemcitabine)

      Recruiting
      • Metastatic Pancreatic Adenocarcinoma
      • Shanghai, Shanghai, China
        Shanghai Cancer Center
      Aug 29, 2023

      PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With

      Recruiting
      • Pancreatic Cancer
      • +4 more
      • PET Scan
      • +3 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Feb 10, 2023

      Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Phoenix, Arizona
      • +5 more
      Dec 15, 2022

      Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer Trial (LB1908)

      Not yet recruiting
      • Gastric Cancer
      • +3 more
      • LB1908
      • (no location specified)
      Sep 9, 2022